Mesenchymal Stem Cells in Clinical Trials for Immune Disorders.

Autor:	Li, Zongjin, Han, Zhibo, Han, Zhong-Chao
Předmět:	MESENCHYMAL stem cells IMMUNOLOGIC diseases PLATELET count THROMBOPOIETIN receptors CLINICAL trials B cells CYTOLOGY HEPATOCYTE growth factor UMBILICAL cord
Zdroj:	Global Medical Genetics; Sep2024, Vol. 11 Issue 3, p196-199, 4p
Abstrakt:	A recent article in Global Medical Genetics discusses the use of mesenchymal stem cells (MSCs) in clinical trials for immune disorders. MSCs have unique properties, including regeneration and immunomodulation, which make them a promising therapeutic approach. The article highlights a phase I trial that used human umbilical cord-derived MSCs (UC-MSCs) to treat refractory immune thrombocytopenia (ITP), a hemorrhagic disease resulting from an immune imbalance. The trial showed that UC-MSCs increased platelet counts and improved bleeding symptoms in patients with refractory ITP. MSCs have the potential to treat various immune-related conditions, and further research is needed to understand their distribution and metabolism in organ tissues. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.